1
measurements into "low", "medium" and "high" categories based on observed standard deviation, we see a significant 23 relationship between phenotype and diversity (fisher-exact p = 0.01), with high diversity associated with ASD ( Figure 1) . 24
However, performing a rank sum test using each metric, we found no significant difference between cohorts. Although the 25 variance of diversity (distribution of scores) in the ASD cohort was significantly greater than the NT cohort (bootstrap p < 26 .001; Figure 1 ). Shannon diversity was also significantly related to bowel movement quality (fisher-exact p = .02), with 27 low diversity associated with diarrhea, but not significantly related to bowel movement frequency (fisher-exact p = .17) 28 29
Permutation Test on Sibling Pairs to determine ESVs that differentiate between ASD and NT. 30
Ten ESVs were determined to be differentially abundant between sibling pairs (ASD vs. NT) as determined by a 31 permutation test with FDR correction (Table 2; SI 7). The mean differential abundance drawn from the null distribution 32 was never more extreme than the actual differential abundance mean, and all p-values were 0, and increased to 9.36 x10 -3 33 upon correction (see distribution plot in SI H). The genera Aggregatibacter, Anaerococcus and Oscillospira were 34 significantly enriched in the ASD cohort, while Porphyromonas, Slackia, Desulfovibrio, Clostridium colinum, and 35
Acinetobacter johnsonii were enriched in the NT cohort. 36 37
Models to Maximize the Likelihood of Detecting Low Abundance Species 38
We implemented a mixture model using a zero-inflated Gaussian (ZIG) distribution of mean group abundance for each 1 ESV in metagenomeSeq (35), in order to quantify the fold change in taxa between the ASD cohort and the NT cohort. 2 This analysis again revealed 10 ESVs differentially present in the two cohorts: four were enriched in the ASD cohort 3 (Table 2) , and six were enriched in the NT cohort. The NT cohort was enriched in the Lachnospiraceae (five of six ESVs), 4
including Coprococcus catus, Clostridium colinum, and the genera Bifidobacterium. In comparison, the ASD cohort was 5 enriched in Ruminococcus and Holdemania, as well as the species Bacteroides uniformis and Clostridium celatum. 6
We also used a Negative Binomial Distribution Analysis to Identify ESV between ASD and NT, through which we 7 identified a single ESV, from the genus Bacteroides (ESV1), enriched in the ASD cohort. Among the aforementioned 8 statistical analyses, the microbial genus types identified in more than one statistical abundance test in the ASD cohort 9
included the family Ruminococcaceae (by three ESVs including the genera Oscillospira and Ruminococcus), and the 10 genus Bacteroides (by two ESVs). The NT cohort presents six ESVs belonging to the family Lachnospiraceae. 11 12
Functional Profile Prediction 13
The software Piphillan predicted ~6900 active KEGG Orthologs (KO) that were part of ~170 metabolic pathways as 14 defined by KEGG Brite. Overall, we were able to associate 105 ESVs with full genome annotations. From the predicted 15
KOs that were present in these genomes, we observed 17 predicted metabolic pathways with significantly differential 16 abundance between ASD and NT. Two pathways were significantly enriched in the ASD cohort: Flagellar assembly 17 (ko02040), and Aminoacyl-tRNA biosynthesis (ko00970) ( Figure 2 ). Fifteen pathways were significantly enriched in the 18 NT cohort, including Butanoate metabolism (ko00650), Propanoate metabolism (ko00640), Sulfur metabolism (ko00920), 19
Phosphotransferase system (ko02060), and microbial metabolism in diverse environments (ko01120). A full list of 20 significantly differential pathways is in Figure 2 . 21 22 DISCUSSION 23
Crowdsourcing Recruitment 24
By targeting the Internet-active autism community, we were able to crowdsource study subject recruitment and reach our 25 targeted sample size for each cohort in a short amount of time. This methodology allowed us to collect data efficiently and 26 effectively and to recruit participants from diverse geographical areas. 27 28
Lifestyle, Dietary Practices and GI symptoms 29
This study highlights ASD biomarker candidates while minimizing the impact of confounding environmental factors by 30 crowdsourcing recruitment of ASD child-subjects who have age-matched NT siblings to act as study controls. By 31 recruiting only sibling pairs who are within 2 years of age of one another, living in similar home environments, and eating 32 similar diets (see SI 5), we successfully controlled for diet and lifestyle among our two cohorts. Using this approach of 33 working with sibling cohorts, other studies have also showed very similar microbial structure between the two cohorts 34 (36) to the point of not being able to identify taxa specific to one or the other cohort. We observed no overlap between factors that heavily influence the microbial structure (SI 3) and the factors that were 1 significantly different between the ASD and the NT cohorts (Table 1) . Therefore, it is unlikely that the ESVs identified as 2 ASD or NT biomarkers were differentially abundant due to diet or lifestyle as confounding influences. 3 4
We did not observe significant differences in the GI motility or stool quality between cohorts, however, there was an 5 increased prevalence of dairy and gluten sensitivities among ASD child-subjects which may imply a propensity for GI 6 distress. Dairy and gluten sensitivities have been previously found to be associated with children with ASD (37-39). We 7 also observed an increase in special dietary restrictions among our ASD child-subjects, which could imply that many 8 parents had already implemented limitations to their child's diet to alleviate any potential or previously identified 9 gastrointestinal issues. Perhaps due to high parent involvement, we did not observe the expected differences in GI motility 10 or gastrointestinal abnormalities. Failure to detect systematic GI distress in ASD could also be attributed to differences in 11 study populations, as older siblings with wider intervals in age as were included in Son et al. are more likely to have more 12 variable lifestyles and therefore greater differences in GI state. 13 14
Microbial Community Diversity 15
There is much debate in the literature as to whether microbial diversity is significantly different in children with ASD 16 versus neurotypically developing children. While we found no significant rank sum relationship between alpha diversity 17 of the microbiota and ASD diagnosis, we observed a significant relationship when considering samples as "High", 18 "Medium", or "Low" diversity. This finding implies that more or less gut microbiome diversity does not directly translate 19
to more or less benefit in the case of ASD, but rather that diversity should be viewed more broadly as a general 20 contributing metric. The variance in diversity scores was significantly greater in the ASD cohort compared with the NT 21 cohort, which may explain some of the discrepancies seen in smaller cohort studies such as those conducted by Finegold 22 et al. (2010) , Kang et al. (2017) , and Hsiao et. al. (2013) , which respectively report increased, decreased, and unchanged 23 microbial diversity in an ASD cohort. Notably, in our ASD cohort, low diversity seemed strongly related to parent-24 reported diarrhea occurrences. Therefore, it is possible that studies that specifically enrich for significant gut abnormalities 25 when recruiting ASD subjects may unwittingly enrich for decreased ASD microbial diversity. This finding of greater 26 variance in the diversity of ASD microbiota suggests that perhaps the 'Anna Karenina principle' is at work in ASD, 27
whereby there are more ways to be dysbiotic than non-dysbiotic, hence it is more probable to identify a greater range of 28 alpha diversity scores in dysbiotic individuals (40). 29
30

Differential abundance analysis of microbial species 31
This study was designed to include controls that match as exactly as possible the lifestyle and environment of the autism 32 samples in order to allow for better reproducibility and more robust association exploration. There is a concern that fecal 33 bacteria from ASD cases could transfer to neurotypical control siblings, thus obscuring signal and not allowing us to 34 observe differences between the ASD typified gut and the neurotypical gut (40). This may be the case; however, this type 35 of contamination only serves to obscure signal, not to create spurious results. Therefore, while there may be true 36 biological associations not reported here, the associations observed from this cohort are not likely to be spurious. 37 8 To improve the taxonomic resolution of the analyses, this study relied exclusively on ESVs, meaning the taxonomic 1 comparisons were performed without any clustering of 16S rRNA amplicon sequences (Table 2) (41). Importantly it also 2 produces single sequence variants which can be reproducibly detected between studies and across sequencing runs, 3 reducing potential batch effects and improving future meta-analyses (42) . 4
It should be noted that while increased resolution can help improve reproducibility, no singular species, genus, or family 5 can be considered homogeneous, and the functioning of any microbial group can vary widely based on circumstances 6
including most recent diet, influence of other microbial community members, and strain level variation. The same species 7 can manifest different effects on host physiology, but we report here cohort-wide associations that appear robust in a large 8 subset of our population. 9 10
ESVs enriched in the ASD cohort 11
We provided in Table 3 & Table 4 a comprehensive list of biological information and information related to other reports 12 on each bacterial associations with ASD and other pertinent phenotypes. Our findings agree overall with literature that 13 states that Bacteroides genus and families such as Erysipelotrichaceae and Clostridiaceae (member of Clostridial cluster I) 14
have already been widely reported as enriched in ASD (see Table 3 ). We also observed that members of Clostridial cluster 15 IV (genus Ruminococcus), and ESV5 which belongs to the family Pasteurellaleae, are both enriched in the ASD cohort. 16
This entire family was previously reported as being depleted in ASD participants (43); this discrepancy could be 17 explained by the study's aggregation of all Pasteurellaleae, while we implicate a single member of the family. 18
Pasteurellaleae was also detected as one of the most abundant bacterial family in children with developmental disabilities 19 in Japan (44) , supporting its potential association with atypical behavioral phenotypes. Finally, we also found that the 20 genus Anaerococcus (ESV5) was enriched in the ASD cohort which to our knowledge, has not yet been reported in 21 previous research literature. 22
23
ESVs depleted in the ASD cohort 24
Our analysis identified five ESVs belonging to the Lachnospiraceae family that are depleted in the ASD cohort and 25 enriched in the neurotypical cohort. This family overall has already been reported as associated with autism phenotype 26 (see Table 3 ). Of these ESVs, the RDP classifier was only able to assign two species names, and we were only able to 27 identify three genomes carrying similar ribosomal sequences ( Table 2) , indicating that we may have identified novel 28 variants from our analyses (45, 46).These homogeneous phylogenetic groups of ESVs seem especially interesting as they 29 cluster near each other on the 16S rRNA phylogenic tree ( Figure 3 ). Additionally, members from the Clostridial cluster 30 IV were associated with ASD, while members from the Clostridial cluster XIVa were associated with the control cohort. 31
We could hypothesize that these two families exhibit metabolic pathways that are distinct among their functional 32 redundancies. As microbes from this genus are some of human gut-associated microbiomes main butyrate producers, we 33 examine the differences in butyrate production pathways of these two clusters in our pathway analysis below. 34
The genera Desulfovibrio and Bifidobacterium were also depleted in the ASD cohort, consistent with results from at least 35 3 other studies (see table 3 ). Bifidobacterium has been characterized for its ability to normalize gut permeability (16), and 36 lack of this genus has been hypothesized to facilitate translocation of harmful microbial metabolites from the gut to the 37 blood. Our analysis also pinpoints the possible importance of the genus Slackia in the neurotypical cohort, which was 38 depleted in our ASD cohort. Finally, we identified two more families depleted in the ASD cohort, Porphyromonadaceae 1 and Moraxellaceae, which respectively produce butyrate or use it as the sole source of carbon. 2 3
Pathway analysis 4
Using the pipeline Piphillin (47) to infer KOs from our ESVs, and performing a GSEA using the KOs, we identified 17 5 predicted pathways associated with either cohort. Predicted pathway abundance in this analysis is defined by the relative 6 potential capacity of a present bacterial genome to produce any active enzymes in a given biological pathway. It should be 7 noted that connecting enriched predicted pathways to the potential biomarker ESVs reported can be tenuous, as Piphillin 8 was only able to match 6 of our 21 markers to full genomes and extract their associated KOs. Notable differentially 9 predicted pathways include (1) butanoate metabolism, glycolysis and pyruvate metabolism, (2) propanoate metabolism, 10
(3) sulfur metabolism, (4) aminoacyl-tRNA biosynthesis, (5) the phosphotransferase system, and (6) microbial 11 metabolisms in diverse environments. Additionally predicted pathways comprised more general functions (e.g., 12
biosynthesis of antibiotics, biosynthesis of secondary metabolites, carbon metabolism, and two-component system 13 pathways) or were only detected in one ESV biomarker (e.g. flagellar assembly). 14
15
Butyrate Production Pathway 16
The potential role of short chain fatty acids (SCFAs) in autism has been discussed in multiple studies. Wang et al. 17 reported elevated SCFA concentration in children with ASD (48), while two other studies reported the opposite trend 18 when looking at total SCFAs (9, 49). MacFabe et al. found that intravenous administration of the SCFA propionate 19 induced ASD typified behavior in mouse models, though it is likely that propionate injected intravenously may have a 20 different effect compared with propionate originating from GI-microbial fermentation (50). Butyrate, in particular, has 21 been proposed as a potential major mediator of the gut-brain axis either through modulation of the density of cholinergic 22 enteric neurons through epigenetic mechanisms, or through direct modulation of the vagus nerve and hypothalamus (51). 23
In our cohort, we observe an enrichment of microbial genomes capable of butyrate metabolism, implying that butyrate 24 production and consumption pathways, in the stool-microbiome of NT participants ( Figure 2 ). Butyrate production 25 pathways in commensal microbial species and pathogens are thought to have evolved divergently; there are 4 pathways 26 for butyrate production each branching from a different initial substrate: Pyruvate, 4-aminobutyrate, Glutarate, and Lysine 27 (52). The by-products and influences of these major butyrogenic pathways could be relevant to host physiology. In our 28 cohort, the predicted bacterial genetic potential in NT samples showed an enrichment for KOs associated with butyrate 29 production from pyruvate, while in the ASD samples, the predicted functional potential was enriched for butyrate 30 production via the 4-aminobutanoate (4Ab) pathway ( Figure C ). 4Ab is a neurotransmitter and its biosynthesis can 31 directly interfere with the amount of available glutamate (52). This pathway can also potentially release harmful by-32 products such as ammonia (52), which were found elevated in feces of children with ASD (48). Genes identified as part of 33 the pyruvate biosynthesis pathway were either found in both cohorts or only in predicted genomes associated with 34 biomarkers from the NT cohort ( Figure 2 ) (SI 9 panel B). 35 36 Propionate pathway: The predicted pathways for the synthesis of propionate, another SCFA, appears depleted in the 1 ASD cohort ( Figure C) . This pathway has the potential to generate isopropanol, which has recently been found at a 2 significantly greater concentration in the feces of children with autism (43). 3
Sulfur Pathway:
The association between the predicted sulfur pathway and the NT cohort, though somewhat surprising, 4 parallels our finding of Acinetobacter and Desulfovibrio enrichment in the NT cohort. The reactions detailed in SI 9 panel 5 D suggest an imbalanced within the sulfur cycle, which has already been hypothesized as possible route modulating the 6 gut-brain interaction in autism (53). 7
Aminoacyl-tRNA Biosynthesis Pathway: As expected, the vast majority of the aminoacyl-tRNA biosynthesis pathway 8 is predicted to be present in all identified ESVs. Some enzymes from this pathway, specifically L-glutamine amido-ligase 9 directly affect the availability of neurotransmitter precursors (SI 9 panel F) (54). 10
Phosphotransferase system: We also observed differential abundance of predicted carbohydrate uptake pathways within 11 the ESVs associated with each cohort: the ESVs associated with ASD seemed to show a much greater variety of 12 carbohydrate transporters (SI 9 panel G). 13
Microbial metabolism in diverse environments: This high level category comprises many different pathways, which 14
were not individually found enriched in either cohort. It is however interesting to note that this KEGG category is 15 associated with several metabolites already known in the literature as enriched or depleted in subjects with ASD ( Figure  16 2). Among them were p-cresol (43), and ammonia (49) that have been found in greater abundance in the feces of children 17 with autism; SCFAs (propanoate and acetate), which have mixed reports associating them with either children with ASD 18 or controls (9, 49, 55); and neurotransmitters such as L-glutamate and GABA, which tend to be respectively greater and 19 lower in feces of children with ASD, respectively (43). Glutamine, found in greater levels in the plasma of ASD 20 participants (43), also belongs to this KEGG pathway, as do several metabolites such as nicotinate and aspartate, another 21 neurotransmitter (43, 49, 56). 22
Et al 23
Power Calculation and Sample Size 24
Likelihood-ratio-test statistics for a Dirichlet-Multinomial parameter test comparison showed that to reach an acceptable 25 power (>0.9), we needed to include a minimum of 45 child-subjects per cohort. We were successful at screening, 26 recruiting, sequencing, and analyzing 60 ASD and 57 NT child-subjects (SI 9). While this analysis does not calculate the 27 power for each of the tests we performed, the Dirichlet-Multinomial distribution does allow power calculations for 28 experimental design and population parameter estimations using a fully parametric approach. And though we cannot 29 relate the verification of sufficient sample size to the non-parametric permutation test, we can conclude that our sample 30 size is sufficient for reproducibility in the results from the zero-inflated Gaussian and DESeq2 models. While these results show promising microbial differences between autism and typically developing children, potential 34 limitations included reliance on self-reported information, limited identification of species or strain level variants, limited 35 single time-point sampling, and lack of consideration of host genetic variation. 36
While we safeguarded against self-report bias through two validated machine-learning algorithms that adapt well to 37 mobile testing, there remains bias in self-report of diagnosis may remain. In particular because we only required MARA 38 for the child with ASD, we could not confirm the typical development of their siblings. In addition, the compliance with 1 the optional request for video was slightly under <50% of the cohort studied. While it was encouraging to see perfect 2 alignment between the MARA and the video classifier outcomes, bolstering confidence in the confirmation of self-report, 3 it would be better to require this dual check for all participants in future work. 4
Although widely used (19), self-reported GI symptoms can also suffer some discrepancies when compared to a pediatric 5 gastroenterologist reported data (57). Furthermore, while we observed physiological distinctions between the 6 microbiomes of the cohorts on the level of exact sequence variants, it was often not possible to assign a taxonomic 7 annotation or full genome to these sequences because of incomplete coverage in public databases. As the predicted 8 pathways discussed were highly dependent on availabilities of full genome information, further metagenome and multi-9
Omics analyses in this space will be needed to confirm the metabolic hypotheses presented. 10
Finally, this study only collects one microbiome sample from each participant child and does not consider the influence of 11 genetic variation between subjects or cohorts. A prospective and longitudinal study, described in Future Work, will 12 ameliorate these limitations and significantly contribute to our understanding of the gut-brain interactions by accounting 13 for the host genotype, gut microbiome, phenome, and metabolome of more than 200 age-matched sibling pairs with and 14 without ASD. 15
16
Future Work 17
This study has provided potential microbial biomarkers, both taxonomic and functional that associate the stool-associated 18 microbiome with the ASD phenome. These findings may be due in part to the fact that we were able build a larger sample 19 than previous studies on the microbiome and ASD, however, it will be necessary to continue sampling this modality in a 20 larger and even more diverse cohort. Our study to confirms that crowdsourcing is a viable and cost effective way to do so. 21
Thus our future work will take a similar angle but on an expanded population and will additionally move from single to 22 multi-time-point sampling of the subjects to control for unrelated environmental influences on the gut microbiome. In 23 addition, future work should combine the microbiome and phenotype, with the genome to enable more precise 24 stratification of the relationship between microbiota and the Autism Spectrum and improve our understanding of the host-25 microbiome interaction as well as facilitate the discovery of more clinically useful autism biomarkers. This study phase 26 has paved the way towards creating a more robust study where we will incorporate the three aforementioned modalities. 27
We will also aim to validate whether specific microbial taxa and metabolisms are causally associated with ASD through 28 improved characterization of the microbiome (e.g. metagenomics, metabolomics, etc.) in human longitudinal studies, 29
animal studies to demonstrate causation, and human interventional studies that target the microbiome 30 31
Conclusion 32
The aim of this study was to explore the association between the composition of the gut microbiome and the ASD 33 phenotype in order to predict mechanism of association and to identify taxonomic and functional biomarkers and targets 34 for future therapeutic research. Using a novel crowd-sourcing approach, we recruited 71 ASD/NT young sibling pairs, 35 thereby limiting the confounding factors of age, lifestyle, diet, and genetics. This improves our confidence in the observed 36 differences in gut bacterial taxa associated with the ASD phenotype. We observed systematic differences in the abundance 37 of specific microbes between the ASD and NT cohorts, including a depletion of five ESVs from the Lachnospiraceae 38 family and two ESVs associated with the genera Desulfovibrio and Bifidobacterium in the ASD cohort, and a difference in 1 membership of clostridial organisms between the cohorts. Taxonomic assignments for short 16S rRNA fragments cannot 2 be used to predict the full genetic functional potential of a microbiome, but using conservative methods we predicted the 3 general functional potential of these microbiota and observed possible differences in the pathways associated with 4 butyrate synthesis, potential harmful by-product and asssociated neurotransmitter production, that warrants further 5 examination. The observed predicted differences in stool-associated microbial metabolic potential between ASD and NT 6 siblings are worthy of future investigation into causality, and could represent opportunities for therapeutic intervention. Board protocol (eProtocol 30205). To target and inform the autism community of the study, we crowdsourced study 12 subject recruitment via popular social media networking platforms including Twitter, Facebook, autism-focused Yahoo 13
Groups, and a press released article from National Public Radio. In addition, we engaged with non-profit and for-profit 14 companies who informed their community of the study via their social media platforms and email lists. 
Sampling Kits 21
After they completed the online surveys, research staff mailed sampling kits to families for at-home stool collection. Each 22 sampling kit included two sets of collections tubes and swabs to collect stool samples, for both the child with ASD and his 23 or her neurotypically developing sibling, instructions on how to collect the samples, and a detailed, 53-question dietary 24 questionnaire for each child (see Supporting Information SI 11). Participants returned the samples to the research staff via 25 prepaid and pre-labelled packaging (60). 26
27
ASD Diagnosis Confirmation 28
To confirm the parent-provided ASD diagnosis of a child-subject, we applied two machine learning classifiers, one based 29 on a parent-directed questionnaire (29, 32) and one based on a home video of the child with ASD (28, 29, 33) . The 30 parent-directed questionnaire is described below as "Mobile Autism Risk Assessment or MARA" and the video-based 31 classifier is referred to as "video classifier. Due to both privacy and technical barriers to video upload, we made the video 32 upload optional but required that all subjects complete the MARA as a strict inclusion criterion. We confirmed the self-33 reported diagnosis of the child using MARA and, when available, both the MARA and the video classifier. When both 34 were available, concordance in outcome from both classifiers with the self-reported diagnosis was required for a sample to 35 be included in our study. 36 37 Mobile Autism Risk Assessment 1 Participants electronically completed the clinically validated Mobile Autism Risk Assessment (MARA) (32) (29). This 2 system uses a set of 7 behavioral features developed through machine learning for rapid screening for autism. The 7-3 feature set is measured through parent-report in a questionnaire on a mobile device. Each feature is scored by the parent 4 on a scale from 0 to 4, 0 being most impaired and 4 being least impaired. The features focus on the child's language 5 ability, make-believe play, social activity, restricted and repetitive behaviors, general signs of developmental delays by or 6 before age 3, and eye contact. The responses generate a score that classifies the child as either "ASD" (positive score) or 7 "no ASD" (negative score). 8 9
Video Analysis 10
In addition, we requested (as optional) a home video of their child with ASD via our secure study website. For a video to 11 be eligible for analysis, we asked that it include social interaction, use or play with objects in the video, be at least two 12 minutes long, and clearly show the child's face and hands. The specific details of scoring and the validation of the 13 classifier are described in previous publications (28, 29, 33) . For the purposes of this study we had at least 3 video raters 14 who were blind to diagnosis independently tag the specific behavioral features that our video classifier requires to produce 15 a risk score. We took the majority consensus diagnosis as the outcome for comparison with the caregiver's self-reported 16
diagnosis. 17
To safeguard against ascertainment bias due to increasing familiarity, we required our video analysts to score an unlabeled 18 mixture of ASD participant videos and similar home videos of neurotypical children ages 2-7 years mined from 19
YouTube's publicly available video repository. The responses to each question were scored on a scale from 0 to 4, 20 generating a classification of the child as either "ASD" or "no ASD". Similar to the MARA, the outcome is a probability 21 score that indicates both class as well as severity of phenotype. 22 23
Lifestyle and Dietary Practices 24
Participants electronically completed dietary and lifestyle questionnaires on behalf of their children, using a 5-point 25 frequency-based Likert scale and categorical answers (Supplementary Information SI 11). Questions covered dietary 26 habits (e.g., How many servings of vegetables does your child eat in a typical week?), lifestyle habits (e.g., How many 27 times a week does your child exercise?), and other pertinent information (e.g., Was your child born by C-section?). 28
We investigated systematic differences in the dietary habits of lifestyles of children with ASD as compared to NT 29 children. Categorical data items were assigned either 1 or 0, and Likert scale items were assigned a value from 1 to 5 (1 = 30 "Never," 2 = "Occasionally," 3 = "Sometimes," 4 = "Often," and 5 = "Always"). Differences of qualities with ordinal 31 values were investigated using a linear-by-linear association test, and qualities with categorical values were tested using a 32 chi-squared test. To verify that family relation was a practical criterion to ensure similarity between case and control 33 lifestyle and dietary habits, we performed a permutation test (999 permutations) on the Euclidean distances between 34 participants' numerical responses. Data were standardized to mean as 0 and variance as 1 to account for the differences in Apprill:2015gb, (61-63). DNA was extracted using the 96-well Powersoil DNA Isolation Kit (MO BIO, Carlsbad, CA). 2
We utilized the manufacturer's protocol with the following modification: after the addition of the sample and solution C1, 3 we partially submerged the sealed extraction plates in a water bath for 10 minutes at 65°C. We amplified the extracted 4 DNA using the 5PRIME MasterMix (5 PRIME, Inc, Gaithersburg, MD) and the 515F/806R primers for a final 5 concentration of 0.2µM per primer. Thermocycler settings for generating amplicons were 3 minutes at 94°C, then 35 6 cycles at 94°C for 45 seconds, 50°C for 1 minute, and 72°C for 1.5 minutes, with a final extension for 10 minutes at 72°C. 7
After PCR, we quantified the DNA concentration of each sample using the Quant-iT PicoGreen dsDNA Assay kit and 8 then pooled to 70 ng DNA per sample. We generated clean pools using the QIAquick PCR Purification Kit (QIAGEN, 9
Hilden, Germany). The clean pools were then submitted to the Environmental Sample Preparation and Sequencing 10
Facility at Argonne National Laboratory to be sequenced on an Illumina MiSeq using V4 chemistry. 11 12
Sequence Filtering, Chimera Removal, Taxonomic Assignment and Phylogenic Tree 13
Raw sequences were processed using the workflow available in the software package DADA2 (41), which models and 14 corrects amplicon errors. Reads were trimmed to include base pairs 10 through 140 and truncated at the first instance of a 15
Phred quality score less than 20. Reads with more than two expected errors were filtered out. Reads were then de- 
Analysis of Alpha-Diversity Differences 36
We calculated alpha-diversity for each sample using Shannon-Weiner diversity, a traditional metric that takes into account 37 richness and evenness of taxonomic species, and Phylogenetic Diversity, a metric that measures the total length of 38 phylogenetic branches necessary to span the set of taxa in a sample (39). We then used a Wilcoxon rank sum test (68) to 1 quantify the significance of differences observed between the two cohorts. Next, we performed 1000 bootstrap 2 simulations to calculate the variance of diversity metrics observed in each cohort and again used a rank sum test to 3 quantify significance of the difference in variances. 4 5
Identification of Dietary and Lifestyle Habits Influencing the Microbial Community 6
To determine whether or not the parent-reported dietary and lifestyle questionnaires contained influential data and insight 7 into the microbial communities observed in our samples, we used a PERMANOVA test (ADONIS function in vegan 8 package) on Bray-Curtis distances (13). We also performed a test to measure the homogeneity of the dispersion 9 (PERMDISP2 procedure) of each cluster in order to be more confident that the cluster-specific centroids were robustly 10 different rather than due to disparities in cohort dispersions (19) . 11 12
Permutation Test on Sibling Pair Differentials 13
In addition to community level trends, we investigated differential abundances of specific taxa. We ran a permutation test 14 on mean taxa abundance differences between sibling pairs to determine if any taxa were systematically enriched or 15 depleted in our ASD samples when compared to our NT controls. We selected DeSeq2 as a normalization method to 16 minimize batch effect and noise from differences in sampling depth while maintaining the expected dataset properties 17 (69). We expected that the microbiome compositions of age-matched sibling pairs would be closer to each other than to 18 any other samples in the cohort, due to the environmental and genetic similarities shared by young siblings living within 19 the same household. Additionally, we resampled and resequenced samples from eight individuals, with at least six months 20 in between samplings, to examine the similarities of the results and confirm that the quality of the samples was maintained 21 over time. Just as in the case of siblings, we expected samples from the same individual to contain microbiome 22 compositions very similar to each other. We investigated the suitability of three commonly used normalization techniques: 23 CSS normalization, DeSeq2 normalization, and log transformation, and found that DeSeq2 best matched above stated 24 expectations (SI 13). This method performs variance stabilization to normalize counts with respect to library size and 25 heteroskedasticity (70). 26
27
We first excluded all samples that were singletons resulting from quality control or from third siblings (sibling furthest in 28 age was removed). We were left with 55 sibling pairs, each sequenced on the same day, on the same instrument and to 29 similar depths. Using DeSeq2 normalized taxa abundances, counts in the NT siblings were subtracted from those in the 30 ASD siblings and averaged across all samples for each taxon. For each taxon, we simulated a null distribution of the 31 average sibling differences by repeating the above procedure with permutated sibling pairs and phenotype assignments 32 10000 times. Lastly, we calculated a p-value as the number of times the null hypotheses produced a value more extreme 33 than the actual value observed (see SI H). Null distributions remained stable well before 10000 permutations. We assessed stability by comparing the value of the ks 1 test statistic to the null distribution shapes at increments of 500 simulations. At 10,000 simulations, the maximal ks test 2 statistic over all taxa (when increasing from 9000 to 10000 simulations) was 4.8 * 10^-3. 3 4
Models to Maximize the Likelihood of Detecting Low Abundance Species 5
Given the sparsity of 16S sequencing due to sequencing depth limitations, we used differential ribosomal analysis based 6 on the negative binomial distribution and zero inflated Gaussian analysis, to estimate log-fold changes of taxa abundances 7 between our ASD and NT groups (71). 8 9
Differential Ribosomal Analysis Based on the Negative Binomial Distribution 10
We performed differential analysis of taxa counts between groups by modeling taxa abundances under a negative 11 binomial model using the DESeq2 framework. This method performs variance stabilization on taxa counts and then fits a 12 zero-inflated Gaussian model, it was necessary to normalize data in a way that does not change the distribution of the 23 variance of taxa across samples. We used cumulative sum scaling (CSS) (35) to account for under-sampling and increase 24 the sensitivity and specificity of identifiable taxa. CSS is a technique that mitigates bias coming from features that are 25 preferentially amplified in a sample-specific manner. CSS divides the feature counts for each sample by the sum of feature 26
counts with values less than that of the median (or chosen percentile), rather than by the total counts in that sample (as in 27 total-sum normalization). Counts are then multiplied by a normalization constant that is the same across samples to ensure 28 normalized counts have interpretable units. The method models each taxon count as a mixture model of a point mass at 29 zero and a normal distribution parameterized by the observed taxa distribution. 30 31
Functional Profile Prediction using Piphillan 32
We inferred metabolic activity using Piphillan (47), a bioinformatics software package designed to predict metagenome 33 functional content from marker gene (16S) surveys. Piphillan aligns 16S sequences to sequences in the GreenGenes 34 database (65), and assigns functional profiles based on 97% match of 16S sequences. 16S sequences that do not match a 35 database entry are assigned the functional profile of their nearest neighbor. We chose this software over other alternatives, 36 such as PiCRUST (74) and Tax4Fun (75), because of its high performance on clinical samples and its usage of the most 37 current GreenGenes database. Piphillan was run on DESeq2 normalized data to produce estimates of KEGG ortholog 38 abundances (76-78). We then performed a modified gene enrichment analysis: a set was considered a metabolic pathway 1 as defined by the KEGG Brite database and an element was considered a KEGG ortholog (79). 2 3
Gene Set Enrichment Analysis Using KEGG Orthologs 4
Using KO prediction provided by Piphillan, we distilled the data to define functional pathways as described by the KEGG 5 database <http://www.kegg.jp/kegg/pathway.html> (78). As some KOs contribute to multiple pathways, we first divided 6 the abundance of each KO in a sample by the number of pathways the KO participates in, so that a single functional unit's 7 activity or output may contribute to only one pathway at a time (as a rule of thumb). Then we used the Gage 8 implementation of Gene Set Enrichment Analysis (GSEA) (80) to perform a modified gene enrichment analysis: a set was 9 considered a metabolic pathway as defined by the KEGG Brite database and an element was considered a KEGG 10 ortholog(79). 11 12
Power Calculation 13
We modeled microbial abundances as a Dirichlet-Multinomial, a model which has been proven to successfully reflect the 14 abundances seen in naturally occurring microbial communities (81). Under this model, we estimated Method-of-Moments 15 (MoM) parameters for each taxon and determined the stability of those estimates by comparing likelihood-ratio-test 16 statistics over 1000 Monte-Carlo simulations (82). From this simulation, we can determine the number of samples 17 necessary to reach a given level of power when estimating parameter values. At a rejection threshold value of 0.05, n=70 18 ASD child-subjects and n=70 NT subjects were required to obtain power above 0.99, and n=45 ASD child-subjects and 19 n=45 NT child-subjects was sufficient to provide a power greater than 0.95. Though we do not explicitly use the Dirichlet-20
Multinomial model in further analyses, a high power in this context implies a high power in more complex down-stream 21 analyses that are not able to be simulated. 22
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